NEW YORK (360Dx) – Premaitha Health said that its CE-marked noninvasive prenatal Iona test has been validated for use on Thermo Fisher Scientific’s Ion S5 range of instruments. Its validation, completed in partnership with Thermo Fisher, could potentially broaden Premaitha’s laboratory customer base. With the validation, the Iona test presents a potential NIPT solution for use with the Ion S5 instrument's growing network of laboratories, Premaitha said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.